SSRIs might be responsible for a disturbed sleep cycle (particularly difficulty falling asleep) (53) and this has been linked to the activation of 5-HT2 receptor which leads to mental activation and thus insomnia, and therefore, add up to the pre-existing burden of depressive symptoms. The gene discussed is HTR2A; the disease is insomnia measurement.